Late-breaking trials, registries and innovations

Summary

Chairpersons: A. Vahanian, W. Wijns, S. Windecker
Speakers: C.K. Naber, T. Cuisset, T. Kubo, R. Waksman, M. Guerrero, N. Piazza, D. Dvir, A.P. Kappetein
Panellists: T. Cuisset, F. Hellig, A.P. Kappetein, N. Piazza, R. Waksman

Watch the Hotline session video on Late-breaking trials, registries and innovations during EuroPCR 2016 if you want to learn more about:

  • Biolimus A9 drug-coated stent vs. bare metal-stent in patients presenting with ACS - a prespecified LEADERS FREE ACS substudy
  • Optical frequency domain imaging vs. IVUS in PCI: the OPINION trial - one-year primary endpoint results
  • Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first global registry
  • First look at long-term durability of transcatheter heart valves: assessment of valve function up to 10 years after implantation
  • Three-month outcome of LAA closure in Europe: post-procedural drug regimen, impact of centre experience and leakage. Data from the prospective 1,000 patient EWOLUTION registry

(Session from Tuesday 17 May 2016 11:20-12:20, Main Arena - EuroPCR 2016)